Average Co-Inventor Count = 6.06
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cymabay Therapeutics, Inc. (9 from 43 patents)
2. Ph Pharma Co., Ltd. (1 from 6 patents)
10 patents:
1. 11179359 - Treatment of NAFLD and NASH
2. 11007162 - Methods of reducing small, dense LDL particles
3. 10806735 - Use of neutrophil elastase inhibitors in liver disease
4. 10722483 - Treatment of NAFLD and NASH
5. 10342770 - Treatment of NAFLD and NASH
6. 10188620 - Treatment for NAFLD and NASH
7. 9962346 - Treatment of NAFLD and NASH
8. 9616039 - Treatment of NAFLD and NASH
9. 9381181 - Treatment of NAFLD and NASH
10. 8703776 - Agonists of GPR131 and uses thereof